MiMedx Group Inc (MDXG)
7.455
+0.22
(+2.97%)
USD |
NASDAQ |
May 10, 16:00
7.455
0.00 (0.00%)
After-Hours: 19:20
MiMedx Group Price to Book Value: 7.066 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 6.862 |
| May 08, 2024 | 6.824 |
| May 07, 2024 | 6.910 |
| May 06, 2024 | 6.758 |
| May 03, 2024 | 6.985 |
| May 02, 2024 | 7.109 |
| May 01, 2024 | 6.928 |
| April 30, 2024 | 5.838 |
| April 29, 2024 | 5.933 |
| April 26, 2024 | 5.943 |
| April 25, 2024 | 5.919 |
| April 24, 2024 | 6.094 |
| April 23, 2024 | 6.169 |
| April 22, 2024 | 6.027 |
| April 19, 2024 | 5.961 |
| April 18, 2024 | 5.838 |
| April 17, 2024 | 5.999 |
| April 16, 2024 | 5.904 |
| April 15, 2024 | 6.018 |
| April 12, 2024 | 6.103 |
| April 11, 2024 | 6.264 |
| April 10, 2024 | 6.207 |
| April 09, 2024 | 6.653 |
| April 08, 2024 | 6.539 |
| April 05, 2024 | 6.631 |
| Date | Value |
|---|---|
| April 04, 2024 | 6.650 |
| April 03, 2024 | 6.641 |
| April 02, 2024 | 6.518 |
| April 01, 2024 | 7.058 |
| March 31, 2024 | |
| March 28, 2024 | 7.929 |
| March 27, 2024 | 7.836 |
| March 26, 2024 | 7.846 |
| March 25, 2024 | 8.063 |
| March 22, 2024 | 8.279 |
| March 21, 2024 | 8.402 |
| March 20, 2024 | 8.444 |
| March 19, 2024 | 8.289 |
| March 18, 2024 | 8.114 |
| March 15, 2024 | 8.114 |
| March 14, 2024 | 8.032 |
| March 13, 2024 | 8.186 |
| March 12, 2024 | 8.228 |
| March 11, 2024 | 8.238 |
| March 08, 2024 | 8.402 |
| March 07, 2024 | 8.392 |
| March 06, 2024 | 8.310 |
| March 05, 2024 | 8.238 |
| March 04, 2024 | 8.506 |
| March 01, 2024 | 8.886 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.838
Minimum
Apr 18 2024
8558.18
Maximum
Jan 03 2022
743.52
Average
22.65
Median
Jan 10 2020
Price to Book Value Benchmarks
| TELA Bio Inc | 7.508 |
| Amylyx Pharmaceuticals Inc | 0.2745 |
| CEL-SCI Corp | 6.059 |
| AIM ImmunoTech Inc | 2.108 |
| IGC Pharma Inc | 3.593 |
Price to Book Value Related Metrics
| PE Ratio | 14.91 |
| PS Ratio | 2.961 |
| Price to Free Cash Flow | 33.80 |
| Price | 7.455 |
| Earnings Yield | 6.71% |
| Market Cap | 1.100B |
| Operating PE Ratio | 18.43 |
| Normalized PE Ratio | 14.75 |